D Beaumont
Impact in
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
-
- Pharmacological Effects and Toxicity Studies
- Pharmaceutical studies and practices
Papers in
-
- Epilepsy research and treatment 5
-
- Neuroscience and Neuropharmacology Research 4
- Co-authors
- Alexis Arzimanoglou (1 shared paper)J. H. Livingston (1 shared paper)Jean Aicardi (1 shared paper)P d'Athis (1 shared paper)Olivier Dulac (1 shared paper)Elisabeth Rey (1 shared paper)Catherine Chiron (1 shared paper)G Olivé (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (4 papers)Epilepsia (1 paper)Journal of Child Neurology (1 paper)European Journal of Clinical Pharmacology (1 paper)La Nouvelle presse médicale (1 paper)
In The Last Decade
D Beaumont
9 papers receiving 316 citations
Peers
Comparison fields: 5 of 41
- Psychiatry and Mental health 245
- Pediatrics, Perinatology and Child Health 173
- Cellular and Molecular Neuroscience 119
- Clinical Biochemistry 38
- Rheumatology 39
Countries citing papers authored by D Beaumont
This map shows the geographic impact of D Beaumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Beaumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Beaumont more than expected).
Fields of papers citing papers by D Beaumont
This network shows the impact of papers produced by D Beaumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Beaumont. The network helps show where D Beaumont may publish in the future.
Co-authors
The 25 scholars most cited alongside D Beaumont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 93 | |
| 2 | 1990 | 69 | |
| 3 | 1989 | 63 | |
| 4 | 2000 | 37 | |
| 5 | 1991 | 33 | |
| 6 | 1989 | 23 | |
| 7 | 1989 | 17 | |
| 8 | 1984 | 2 | |
| 9 | Taux sérique de l'enzyme de conversion de l'angiotensine dans la sarcoïdose. Essai de corrélation avec l'activité clinique de la maladie. | 1981 | 1 |
| 10 | 1987 | 0 |
About D Beaumont
D Beaumont is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health, Surgery and Neurology, having authored 10 papers that have together received 338 indexed citations. Recurring topics across this work include Epilepsy research and treatment (5 papers), Neuroscience and Neuropharmacology Research (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Neurological disorders and treatments (2 papers), Bone and Joint Diseases (1 paper), S100 Proteins and Annexins (1 paper), Metabolism and Genetic Disorders (1 paper) and Hemodynamic Monitoring and Therapy (1 paper). The work is most often cited by research in Psychiatry and Mental health (245 citations), Pediatrics, Perinatology and Child Health (173 citations), Cellular and Molecular Neuroscience (119 citations), Clinical Biochemistry (38 citations) and Rheumatology (39 citations). D Beaumont has collaborated with scholars based in France, Spain and Australia. Frequent co-authors include Alexis Arzimanoglou, J. H. Livingston, Jean Aicardi, P d'Athis, Olivier Dulac, Elisabeth Rey, Catherine Chiron, G Olivé, Gérard Pons and R. Pantieri. Their work appears in journals such as British Journal of Clinical Pharmacology, Epilepsia, Journal of Child Neurology, European Journal of Clinical Pharmacology and La Nouvelle presse médicale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.